Paris, France and Camberley, UK – 1 March 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to ordinary shares traded under its ongoing liquidity agreement with Invest Securities SA (the “Liquidity Agreement”). The Liquidity Agreement is governed by French law and is further summarised
Visit PageNews and Events
INFORMATION SUR LE FINANCEMENT
INFORMATION SUR LE FINANCEMENT Paris, France et Camberley, UK – 26 février 2019 – Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT), spécialiste international du diagnostic clinique informe sur sa position financière actuelle et ses plans de financement. La Société confirme que l’exercice 2019 a débuté positivement et qu’il est conforme aux attentes du
Visit PageFunding update
Funding update Paris, France and Camberley, UK – 26 February 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an update on its current position and funding plans. The Company confirms that 2019 trading has started positively and is in line with 2019 management expectations. The Company also continues
Visit Page